Ajinomoto Bio-Pharma Services Receives FDA Approval for High P... - 19 April 2023 22:05

SAN DIEGO, April 19, 2023 /PRNewswire-AsiaNet/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that the United States Food and Drug Administration (FDA) has approved the company's ...

  OMRON Healthcare India Enters Home Heart Monitoring & Manageme... - 18 April 2023 18:00

KYOTO, Japan, Apr. 18, 2023 /Kyodo JBN-AsiaNet/ -- OMRON Healthcare India, a sales base of the leading player in home healthcare monitoring segment OMRON HEALTHCARE Co. Ltd. in India, has announced its foray into the remote home heart monitoring & management segment via collaboration with Tricog H...

  Bugworks Research Inc. to Present Eight Posters at the 33rd Eu... - 17 April 2023 10:00

BANGALORE, DELAWARE CITY and ADELAIDE, April 17, 2023 /PRNewswire-AsiaNet/ -- Bugworks Research Inc., a clinical-stage biopharmaceutical company, is set to present its latest research findings on the novel bacterial topoisomerase inhibitor, BWC0977 at the upcoming 33rd European Congress of Clinical Microbiology & Infect...

  Smith+Nephew signs exclusive distribution agreement to bring u... - 11 April 2023 09:00

LONDON, April 11, 2023 /PRNewswire-AsiaNet/ -- -- Small, disposable, compact and simple to use navigation tool offers surgeons speed and reliability without the financial burden of capital equipment Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces an a...

  Turn Biotechnologies Introduces its Dermatology Platform to th... - 30 March 2023 23:00

MOUNTAIN VIEW, Calif., March 30, 2023 /PRNewswire-AsiaNet/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, announced that it will for the first time share new data for its revolutionary dermatology platform with the internation...

  Hovione and Laxxon Medical Establish an Agreement for the cGMP... - 23 March 2023 00:05

LISBON, Portugal, March 22, 2023 /PRNewswire-AsiaNet/-- This partnership will create an opportunity for the pharmaceutical industry to develop and manufacture clinical materials and secure industrial scale production under cGMP with Hovione, using Laxxon Medical's 3D screen printing technology. Hovi...

  Hovione and Ripple Enter Strategic Partnership to Expand Epide... - 21 March 2023 01:56

LISBON, Portugal March 20, 2023 /PRNewswire-AsiaNet/ Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and Ripple Therapeutics, a leading ophthalmic sustained drug delivery company, have entered a strategic partnership to expand the use of Ripple's Epidel(R) p...

  Sai Life Sciences sets up GMP Kilo Lab in Alderley Park, Manch... - 16 March 2023 00:25

MANCHESTER, England and HYDERABAD, India, March 15, 2023 /PRNewswire-AsiaNet/ -- Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO-CDMO)[https://www.sailife.com/?utm_source=pr&utm_medium=web&utm_campaign=manchester-kilolab], today announced the setting up of a GMP Kilo Lab...

  Nippon Express (Belgium) Joins Pharma.Aero - 15 March 2023 17:00

TOKYO, Mar. 15, 2023 /Kyodo JBN-AsiaNet/ -- Nippon Express (Belgium) N.V./S.A. (hereinafter "NX Belgium"), a group company of NIPPON EXPRESS HOLDINGS, INC., became the first Japanese forwarder to join Pharma.Aero (*) on January 25 this year. Pharma.Aero logo: https://kyodonewsprwire.jp/i...

  Ajinomoto Bio-Pharma Services Awarded Three 'CDMO Leadership A... - 14 March 2023 23:05

SAN DIEGO and TOKYO and WETTEREN, Belgium, March 14, 2023 /PRNewswire-AsiaNet/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, received three CDMO Leadership Awards in the categories Capabilities, Compatibility, and Expertise in both t...